These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35756632)

  • 1. Targeting ALK in Neuroendocrine Tumors of the Lung.
    Akhoundova D; Haberecker M; Fritsch R; Höller S; Kiessling MK; Rechsteiner M; Rüschoff JH; Curioni-Fontecedro A
    Front Oncol; 2022; 12():911294. PubMed ID: 35756632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm.
    Liu Y; Wu S; Shi X; Liang Z; Zeng X
    J Cancer Res Clin Oncol; 2020 May; 146(5):1307-1320. PubMed ID: 32128622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers.
    Xia P; Zhang L; Li P; Liu E; Li W; Zhang J; Li H; Su X; Jiang G
    J Transl Med; 2021 Jul; 19(1):308. PubMed ID: 34271921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
    Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
    Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?
    Batra U; Nathany S; Sharma M; Pasricha S; Bansal A; Jain P; Mehta A
    J Clin Pathol; 2022 Jun; 75(6):405-409. PubMed ID: 33753563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics and diagnostic methods of
    Feng J; Li Y; Wei B; Guo L; Li W; Xia Q; Zhao C; Zheng J; Zhao J; Sun R; Guo Y; Brcic L; Hakozaki T; Ying J; Ma J
    Transl Lung Cancer Res; 2022 Apr; 11(4):617-631. PubMed ID: 35529790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review.
    Chen Q; Zhang J; Wang X; Zong W; Sun L; Qin J; Yin Y
    Front Oncol; 2023; 13():1227980. PubMed ID: 38023218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
    Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
    Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
    Zhang YG; Jin ML; Li L; Zhao HY; Zeng X; Jiang L; Wei P; Diao XL; Li X; Cao Q; Tian XX
    PLoS One; 2013; 8(5):e64821. PubMed ID: 23741400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic pulmonary carcinoids with
    Lei X; Zhu S; Ren D; Ren F; Li T; Zhou N; Li S; Shi T; Zu L; Song Z; Chalubinska-Fendler J; Denis MG; Bernicker EH; Thomas de Montpréville V; Jiang R; Xu S
    Transl Lung Cancer Res; 2022 Jun; 11(6):1176-1184. PubMed ID: 35832448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
    Katayama R; Sakashita T; Yanagitani N; Ninomiya H; Horiike A; Friboulet L; Gainor JF; Motoi N; Dobashi A; Sakata S; Tambo Y; Kitazono S; Sato S; Koike S; John Iafrate A; Mino-Kenudson M; Ishikawa Y; Shaw AT; Engelman JA; Takeuchi K; Nishio M; Fujita N
    EBioMedicine; 2016 Jan; 3():54-66. PubMed ID: 26870817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
    Lin C; Shi X; Yang S; Zhao J; He Q; Jin Y; Yu X
    Lung Cancer; 2019 May; 131():62-68. PubMed ID: 31027700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated isolated 3' signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC.
    Smuk G; Pajor G; Szuhai K; Morreau H; Kocsmár I; Kocsmár É; Pajor L; Kajtár B; Sárosi V; Lotz G; Tornóczky T
    Lung Cancer; 2020 May; 143():80-85. PubMed ID: 32272316
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Canterbury CR; Fernandes H; Crapanzano JP; Murty VV; Mansukhani MM; Shu CA; Szabolcs M; Saqi A
    JTO Clin Res Rep; 2021 Oct; 2(10):100223. PubMed ID: 34746883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Implications of Variant ALK FISH Rearrangement Patterns.
    Gao X; Sholl LM; Nishino M; Heng JC; Jänne PA; Oxnard GR
    J Thorac Oncol; 2015 Nov; 10(11):1648-52. PubMed ID: 26536196
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zheng Q; Zheng M; Jin Y; Shen X; Shan L; Shen L; Sun Y; Chen H; Li Y
    Onco Targets Ther; 2018; 11():4991-4998. PubMed ID: 30154667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
    Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
    Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.
    Vollbrecht C; Lenze D; Hummel M; Lehmann A; Moebs M; Frost N; Jurmeister P; Schweizer L; Kellner U; Dietel M; von Laffert M
    BMC Cancer; 2018 Nov; 18(1):1158. PubMed ID: 30466405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of ALK rearrangements in malignant pleural effusion cell blocks from patients with advanced non-small cell lung cancer: a comparison of Ventana immunohistochemistry and fluorescence in situ hybridization.
    Wang W; Tang Y; Li J; Jiang L; Jiang Y; Su X
    Cancer Cytopathol; 2015 Feb; 123(2):117-22. PubMed ID: 25529354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting from Immunohistochemistry to Screen for
    Ilié M; Goffinet S; Rignol G; Lespinet-Fabre V; Lalvée S; Bordone O; Zahaf K; Bonnetaud C; Washetine K; Lassalle S; Long-Mira E; Heeke S; Hofman V; Hofman P
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.